General Catalyst Group Management, LLC is a private equity and venture capital firm founded in 2000 and based in Cambridge, Massachusetts, with additional offices in North America and Europe. The firm specializes in early-stage and growth equity investments, focusing on a wide range of technology sectors, including advanced materials, clean energy, disruptive technology, healthcare IT, and consumer services, among others. General Catalyst typically invests between $0.05 million and $0.25 million in seed-stage companies and between $10 million and $50 million in growth equity, seeking profitable firms with substantial revenue and EBITDA. Their approach emphasizes mentorship and collaboration, fostering strong relationships with entrepreneurs who share their vision and values. They have managed eight venture capital funds, accumulating around $3.75 billion in capital commitments, reflecting their commitment to supporting innovative companies throughout their growth journey.
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.